Cover Image
市場調查報告書

Shanghai Zerun Biotechnology Co., Ltd.的產品平台分析

Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 328424
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Shanghai Zerun Biotechnology Co., Ltd.的產品平台分析 Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年02月28日 內容資訊: 英文 21 Pages
簡介

Shanghai Zerun Biotechnology Co., Ltd.是總公司設立於中國的生物科技企業,參與新疫苗的開發、製造、商品化。擁有vero細胞製A型肝炎疫苗、預防子宮頸癌用疫苗、利用其他基因重組的VLP(類病毒顆粒)的預防及治療用疫苗之開發平台。

本報告提供Shanghai Zerun Biotechnology Co., Ltd. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Shanghai Zerun Biotechnology Co., Ltd. 的基本資料

  • Shanghai Zerun Biotechnology Co., Ltd. 概要
  • 主要資訊
  • 企業資料

Shanghai Zerun Biotechnology Co., Ltd. :R&D概要

  • 主要的治療範圍

Shanghai Zerun Biotechnology Co., Ltd. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Shanghai Zerun Biotechnology Co., Ltd. :開發中產品概況

  • 臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 藥物研發階段的產品/聯合治療模式

Shanghai Zerun Biotechnology Co., Ltd. :藥物簡介

  • human papilloma virus types 16, 18 (bivalent) virus like particle vaccine
  • EV71 virus like particle vaccine
  • H.pylori vaccine
  • HPV virus like particle vaccine
  • human papilloma virus vaccine

Shanghai Zerun Biotechnology Co., Ltd. :開發平台分析

  • 各給藥途徑
  • 各分子類型

Shanghai Zerun Biotechnology Co., Ltd. :開發暫停中的計劃

Shanghai Zerun Biotechnology Co., Ltd. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC06835CDB

Summary

Global Markets Direct's, ‘Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Shanghai Zerun Biotechnology Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Shanghai Zerun Biotechnology Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Shanghai Zerun Biotechnology Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Shanghai Zerun Biotechnology Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Shanghai Zerun Biotechnology Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Shanghai Zerun Biotechnology Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Shanghai Zerun Biotechnology Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Shanghai Zerun Biotechnology Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Shanghai Zerun Biotechnology Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Shanghai Zerun Biotechnology Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Shanghai Zerun Biotechnology Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Shanghai Zerun Biotechnology Co., Ltd. Snapshot
    • Shanghai Zerun Biotechnology Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Shanghai Zerun Biotechnology Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline Products Glance
    • Shanghai Zerun Biotechnology Co., Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Shanghai Zerun Biotechnology Co., Ltd. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Shanghai Zerun Biotechnology Co., Ltd. - Drug Profiles
    • human papilloma virus [types 16, 18] (bivalent) virus like particle vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EV71 virus like particle vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • H.pylori vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HPV virus like particle vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • human papilloma virus vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline Analysis
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline Products by Route of Administration
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline Products by Molecule Type
  • Shanghai Zerun Biotechnology Co., Ltd. - Dormant Projects
  • Shanghai Zerun Biotechnology Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Shanghai Zerun Biotechnology Co., Ltd., Key Information
  • Shanghai Zerun Biotechnology Co., Ltd., Key Facts
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline by Indication, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline by Stage of Development, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Phase I, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Discovery, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline by Route of Administration, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline by Molecule Type, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Dormant Developmental Projects,2015

List of Figures

  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline by Stage of Development, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Shanghai Zerun Biotechnology Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
Back to Top